25.1 C
New York
Tuesday, June 2, 2026

Tag: society

Callan Family Office Appoints George Burnette as Director of Philanthropic Consulting & Wealth

The appointment expands Callan Family Office’s capabilities at the intersection of philanthropy, wealth planning, and family legacy.
The appointment expands Callan Family Office’s capabilities at the intersection of philanthropy, wealth planning, and family legacy.

Ping An Launches “Ping An Home” Service Brand

Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...

Ping An Launches “Ping An Home” Service Brand

Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy LongevityHONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates...

Quantinuum Signs MOU with Mitsubishi Electric to Launch Strategic Quantum Computing Partnership

Companies aim to explore advanced industrial engineering and design applications leveraging Quantinuum's high-fidelity quantum computing platformTOKYO, June 2, 2026 /PRNewswire/ -- Quantinuum, a leading...

Reshaping PV Value: Sungrow Renewables Launches Smart Module in a Landmark Industry Debut

SHANGHAI, June 2, 2026 /PRNewswire/ -- On June 1, Sungrow Renewables held its 2026 Intelligent Technology Conference in Shanghai. Sungrow Renewables unveiled its new iBuilding...

/C O R R E C T I O N — Ranok Therapeutics/

In the news release, Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic...

InterDigital to Share 6G Leadership, Potential for ISAC and Agentic AI at EuCNC & 6G Summit

At EuCNC, InterDigital will demonstrate 6G leadership in AI, ISAC, and collaborative sensing for 6G verticals, part of the SNS-JU MultiX project

Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and...

ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company engaged in the discovery, development and commercialization of novel, differentiated therapies to address unmet medical needs in cancer, announced that it has received clearance by the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to conduct GLORA-4 study (NCT06641414), a global registrational Phase III study of lisaftoclax (APG-2575), a proprietary Bcl-2 inhibitor, in combination with azacitidine (AZA), for the treatment of patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS).

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis

PAPZIMEOS approval marks a historic milestone for the RRP patient community as the first and only FDA-approved therapy for the treatment of adults with...

Young Mother’s Battle with Arthritis Highlights Need for Timely Access to Modern Medications in BC

VANCOUVER, BC, Aug. 14, 2025 /CNW/ - Eileen Davidson, a Burnaby mother and advocate, is calling on the BC government to modernize its approach to...

The Elie Wiesel Foundation Recognizes Next Generation of Changemakers – Announces 2025 Winners of Prize in Ethics Essay Contest

Four college students from universities across the country will be awarded scholarships totaling $19,000 for their exceptional essays on topical ethical issues in a...

Margaritaville Celebrates Second Annual “Jimmy Buffett Day” with Day of Service on August 29

Global brand-wide initiative honors Jimmy Buffett's legacy through community give-back events benefiting local and global causes ORLANDO, Fla., Aug. 14, 2025 /PRNewswire/ -- Today, Margaritaville...

U.S. Oral Surgery Management Moves into 31st State

U.S. Oral Surgery Management has four new partner practices, including its first in the state of Nebraska.

Peace One Day Transforms Peace Day, 21 September 2025 into the World’s Largest Online Festival for Peace

LONDON, Aug. 14, 2025 /PRNewswire/ -- Peace One Day today announces that its planned 21 September 2025 celebration at the OVO Arena Wembley will now...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSociety